Linus Health
Linus Health is a Boston-based digital health company that sells an AI-driven cognitive assessment platform to health systems, medical practices, life sciences companies, and payers for early detection of Alzheimer's and cognitive impairment, having delivered 225,000+ assessments and 60+ clinical trials.
- Company typePrivate
- Founded2019
- HeadquartersWaltham, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Linus Health does
Linus Health is a Boston-based digital health company that has built an AI-driven cognitive assessment platform for the early detection of cognitive impairment and Alzheimer's disease. The company's core technology combines process-based machine learning with multimodal signal detection (digital stylus drawing data from DCTclock and DCR assessments, speech analytics from Aural Analytics, and physical function data from Kinesis Health Technologies) to generate hundreds of precise metrics from assessments that take approximately 7 minutes, claiming accuracy comparable to 3-hour neuropsychological evaluations. The flagship product, the Core Cognitive Evaluation (CCE), integrates the Digital Clock and Recall test with the Life and Health Questionnaire, and is delivered alongside add-on modules such as the Anywhere remote assessment platform, the RADAR predictive algorithm for payers, the ePSOM person-specific outcome measure for clinical trials, and the Moving Together intervention program from Together Senior Health.
The company sells primarily through an enterprise field sales motion targeting four customer segments: health systems and hospitals (standardized cognitive testing, care coordination, and EHR-integrated workflows), medical practices (early detection at the primary care level), life sciences companies (clinical trial recruitment, safety endpoint monitoring, and outcomes measurement for Alzheimer's, Parkinson's, and ALS studies), and payers/health plans (risk stratification, HCC capture, and RAF score optimization). Pricing is quote-based enterprise SaaS on annual or multi-year subscriptions, with channel expansion now underway through a first-of-its-kind supplier agreement with Provista, a major healthcare group purchasing organization. The platform is FDA-listed, CE-marked, UKCA-marked, EU Class IIa under MDR, ISO 13485 certified, HIPAA and GDPR compliant, and SOC 2 Type 2 certified, and is integrated with Epic, Cerner, Athenahealth, Oracle Health, Xealth, and SMART on FHIR, supporting deployment within the dominant US EHR ecosystems. The company has delivered 225,000+ cognitive assessments, supported 60+ clinical trials, and accumulated 160+ peer-reviewed publications validating its technology.
Linus Health firmographics
Firmographics- Name
- Linus Health
- Legal name
- Linus Health, Inc.
- Website
- https://linushealth.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Linus Health is a Boston-based digital health company that sells an AI-driven cognitive assessment platform to health systems, medical practices, life sciences companies, and payers for early detection of Alzheimer's and cognitive impairment, having delivered 225,000+ assessments and 60+ clinical trials.
- Ownership category
- akta.pro rank
Linus Health industry classification
Industry- Product category
- Digital Cognitive Assessment Platform
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
- akta.pro secondary industries
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ)
Keywords
Where Linus Health is headquartered
LocationHeadquarters
- HQ city
- Waltham
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Linus Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Healthcare Provider Subscriptions: Annual or multi-year subscription licensing of digital cognitive assessment platform to health systems, hospitals, and physician practices. Includes EHR integrations, assessment tools, and reporting capabilities.
- Life Sciences / Clinical Trial Services: Providing digital assessment tools and services to pharmaceutical companies for clinical trial recruitment, safety endpoint monitoring, and outcomes measurement. Supports Alzheimer's, Parkinson's, ALS, and mental health clinical trials.
- Payer Risk Stratification: Platform services for health plans to identify at-risk members, support HCC capture, and optimize RAF scores for risk adjustment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise agreements through Provista GPO |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Linus Health product offering
Product offeringCore offering
Linus Health sells an AI-driven digital cognitive assessment platform that uses multimodal signal detection and machine learning to analyze drawing behavior, speech characteristics, and other digital biomarkers for early detection of cognitive impairment and Alzheimer's disease. The platform is licensed primarily through annual subscriptions to health systems, medical practices, payers, and life sciences companies, with EHR integrations and remote assessment capabilities. It includes flagship offerings such as the Core Cognitive Evaluation (CCE), DCTclock, DAC, the Anywhere remote assessment platform, and the RADAR risk-stratification algorithm.
Product overview
Linus Health offers a digital cognitive assessment platform consisting of multiple integrated products and modules. The core platform centers on the Core Cognitive Evaluation (CCE), which combines the Digital Clock and Recall (DCR) and Life and Health Questionnaire (LHQ). Key products include the award-winning DCTclock, Digital Assessment of Cognition (DAC), and the remote assessment capability (Anywhere). The company has expanded through acquisitions including Kinesis Health Technologies (physical function assessment), Aural Analytics (speech analytics), and Together Senior Health (care programs including Moving Together and RADAR). The platform provides over a dozen cognitive assessments including drawing tests, speech analysis, trail making tests, and functional assessments, all processed through AI/ML algorithms that capture hundreds of precise metrics to detect cognitive impairment earlier than traditional methods.
Differentiator
Problem solved
Functional benefit
Brands
- DCTclock: Award-winning digital cognitive assessment tool that generates insights from the drawing process itself using iPad-based technology
- DCR (Digital Clock and Recall)
- DAC (Digital Assessment of Cognition)
- CCE (Core Cognitive Evaluation)
- Anywhere for Health Systems
- rDAC
- ePSOM
- RADAR
Products and services
- Core Cognitive Evaluation (CCE)
- Digital Clock and Recall (DCR)
- DCTclock
- Digital Assessment of Cognition (DAC)
- Anywhere powered by Linus Health
- Moving Together Program
- RADAR Algorithm
- ePSOM (electronic Person-Specific Outcome Measure)
- Kinesis Health Technologies (QTUG and Kinesis Gait)
Quantifiable outcome
- 90.7% sensitivity and 100% specificity for distinguishing cognitively unimpaired from impaired individuals (DAC)
- +4 more outcomes
Companies that use Linus Health
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
Linus Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability8 records
Feature7 records
Linus Health partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered major, core, flagship, strategic and minor.
- Global Alzheimer's Platform Foundation (GAP)majorGAP announced Sanofi as partner in Bio-Hermes-002 observational study evaluating blood-based and digital biomarkers. Linus Health's digital biomarkers included alongside pharmaceutical partners Biogen, Eli Lilly, Roche.
- ProvistacoreLeading group purchasing organization. Supplier agreement makes Linus Health the first AI-driven brain health solution selected by Provista, expanding access to physician practice clients nationwide.
- Together Senior HealthcoreBrain health company offering Moving Together program and RADAR algorithm for improving patient outcomes and reducing healthcare costs through physical activity interventions.
- Aural AnalyticscoreAcquired to strengthen digital cognitive assessment platform with advanced speech analytics for early detection of cognitive impairments.
- Kinesis Health TechnologiescoreDublin-based company specializing in physical assessment tools for older adults. Kinesis brings sensor technology for gait, balance, and mobility assessment to enhance Linus Health's early detection capabilities. Acquired by Linus Health; key leadership retained.
- Davos Alzheimer's CollaborativeflagshipInternational initiative for early detection of Alzheimer's. Linus technology deployed at seven flagship pilot sites to measurably increase timely, accurate diagnosis.
- Emory HealthcaremajorEmory deploying Linus digital cognitive assessments to expand early detection of Alzheimer's and other dementias. Partnership supports standardization of cognitive screening in primary care.
- Indiana University School of MedicinemajorIU physicians and researchers using Linus screening tools for early detection of Alzheimer's as part of Davos Alzheimer's Collaborative initiative.
- Health Innovation ManchestermajorUK partnership launching cognitive impairment case-finding program across Greater Manchester region to improve early detection in primary care.
- DATAcc by DiMe (Digital Medicine Society)strategicCollaboration with 20+ industry partners to develop digital measures for mental health disorders. Seven measures including cognitive function and speech/language changes using digital health technologies.
- Digital Medicine Society (DiMe)strategicDiMe launched Connected Health Collaborative initiative for tech-enabled aging at home, with Linus Health as coalition partner to develop evidence-based blueprint for older adults.
- Brook HealthminorPartnership for cognitive care assessment combining Brook Health services with Linus Health digital cognitive assessment tools.
Scale indicators7 records
Recent moves6 records
Expansion highlights7 records
Linus Health competitors and assessment
Company assessmentDirect peers
- Cogstate: Public digital cognitive assessment company offering computerized tests and eCOA solutions for clinical trials and healthcare — directly comparable to Linus's DCTclock/DAC and life-sciences segment, including similar pharma trial endpoint services.
- Cambridge Cognition: Digital health company specializing in cognitive assessments for CNS clinical trials and clinical practice, with validated endpoints used by major pharma — overlapping directly with Linus's CCE/DCR and life-sciences business.
- Altoida: Digital biomarker company using augmented reality and AI on smartphones/tablets to detect cognitive impairment — directly comparable in patient-facing, multimodal digital cognitive assessment with FDA breakthrough designation.
- BrainCheck: Digital cognitive assessment platform serving health systems and physicians with rapid screening tools and EHR integration — direct competitor in primary-care and specialty cognitive screening workflows.
- Neurotrack: Digital cognitive health company offering assessment-based tools for early detection of memory impairment and dementia risk — comparable in consumer and provider-facing cognitive screening.
- BioSensics: Developer of wearable sensors and digital outcome measures for gait, balance, and physical function in older adults — directly comparable to the Kinesis Health Technologies business Linus acquired.
Emerging players
- Cumulus Neuroscience: Clinical-stage digital brain health platform combining at-home cognitive and speech assessments with biomarker endpoints for CNS trials — emerging player in the same multimodal-assessment space.
- CeriBell: AI-driven neurology diagnostics platform using EEG and cloud analytics in clinical settings — adjacent digital neurology SaMD competitor with overlapping neurology customer base.
Broad incumbents
- Click Therapeutics: Prescription digital therapeutics (DTx) company developing FDA-cleared SaMD for neurology and psychiatry — broader SaMD/DTx incumbent with adjacent regulatory and commercial pathways.
- Pear Therapeutics (terapeutics-style DTx peers): Digital therapeutics and digital care companies (e.g., Big Health) operating in adjacent brain/mental-health condition management — overlapping in DTx distribution models and payer engagement.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Linus Health social profiles
Digital presenceLinus Health compliance and trust
Trust signalCompliance6 records
Linus Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Linus Health leadership team
Management profileNumber of profiles
Profiles8 records
Linus Health subsidiaries and ownership
Company hierarchySubsidiaries4 records
Linus Health funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Linus Health M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Linus Health
What does Linus Health do?
Linus Health sells an AI-driven digital cognitive assessment platform that uses multimodal signal detection and machine learning to analyze drawing behavior, speech characteristics, and other digital biomarkers for early detection of cognitive impairment and Alzheimer's disease. The platform is licensed primarily through annual subscriptions to health systems, medical practices, payers, and life sciences companies, with EHR integrations and remote assessment capabilities. It includes flagship offerings such as the Core Cognitive Evaluation (CCE), DCTclock, DAC, the Anywhere remote assessment platform, and the RADAR risk-stratification algorithm.
Is Linus Health a public or private company?
Linus Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Linus Health founded?
Linus Health was founded in 2019. It employs 101 to 250 people.
Where is Linus Health based?
Linus Health is headquartered in Waltham, United States, in the North America region.
How does Linus Health make money?
Three revenue lines are on record. Healthcare Provider Subscriptions are the primary driver. The others are life Sciences / Clinical Trial Services and payer Risk Stratification.
Who are Linus Health's main competitors?
Direct peers on record are Cogstate, Cambridge Cognition, Altoida, BrainCheck, Neurotrack and BioSensics. Emerging players are Cumulus Neuroscience and CeriBell. Broad incumbents are Click Therapeutics and Pear Therapeutics (terapeutics-style DTx peers).
Does Linus Health have an API?
No public API is recorded for Linus Health.
What industry is Linus Health in?
Linus Health's product category is Digital Cognitive Assessment Platform. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection. Its NAICS code is 5132 and its SIC code is 7372.